OIRA Conclusion of EO 12866 Regulatory Review

RIN: 0910-AH99         View EO 12866 Meetings	Received Date: 12/06/2023
Title: Medical Devices; Quality System Regulation Amendments
Agency/Subagency: HHS / FDA	Stage: Final Rule
Concluded Action: Consistent without Change	Concluded Date: 01/05/2024
Legal Deadline: None	Economically Significant: No
Publication Date:	Unfunded Mandates: No
Major: Yes	Related To Homeland Security: No
Regulatory Flexibility Analysis Required: Undetermined	Small Entities Affected: No
Federalism Implications: No	Affordable Care Act [Pub. L. 111-148 & 111-152]: No
International Impacts: No	Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No
Pandemic Response: No